|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities | |
| Net loss | |
| Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity | |
| Depreciation and amortization | |
| Stock-based compensation | |
| Non-cash interest | |
| Loss on remeasurement of warrant liabilities | |
| Non-cash lease expense | |
| Provision for credit losses | |
| Provision for excess and obsolete inventory | |
| Other non-cash items | |
| Changes in operating assets and liabilities: | |
| Accounts receivable, net | |
| Inventory | |
| Prepaid expenses and other assets | |
| Accounts payable | |
| Accrued liabilities | |
| Accrued compensation | |
| Lease liabilities | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Purchase of short-term investments | |
| Purchase of property and equipment | |
| Capitalized software costs | |
| Payment of initial direct costs related to operating leases | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from initial public offering, net of underwriting discounts and commissions | |
| Payments for deferred initial public offering costs | |
| Proceeds from issuance of Series C convertible preferred stock, net of issuance costs | |
| Proceeds from term loan, net of issuance costs | |
| Payment of issuance costs related to term loan modification | |
| Proceeds from exercises of stock options | |
| Net cash provided by financing activities | |
| Increase in cash, cash equivalents, and restricted cash | |
| Cash, cash equivalents, and restricted cash at beginning of the period | |
| Cash, cash equivalents, and restricted cash at end of the period | |
| Cash and cash equivalents, end of period | |
| Restricted cash, end of period | |
| Supplemental Disclosure of Cash Flow Information: | |
| Cash paid for interest | |
| Supplemental Disclosure of Noncash Investing and Financing Activities: | |
| Conversion of convertible preferred stock upon initial public offering | |
| Reclassification of warrants from liability classified to equity classified | |
| Vesting of early exercised common stock options | |
| Right-of-use asset obtained in exchange for lease liability | |
| Reclassification of financial commitment asset to debt discount | |
| Unpaid purchases of property and equipment | |
| Capitalized software included in accounts payable and accrued liabilities | |
| Preferred stock warrants issued in connection with term loan modifications | |
| Unpaid deferred offering costs | |
| Cash, Cash Equivalents, and Restricted Cash Information: | |
| Cash and cash equivalents, beginning of period | |
| Restricted cash, beginning of period |
Loading...
